Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burdenKhalid Abubaker, Nuzhat Ahmed|Molecular Cancer|2013Cited by 226
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burdenKhalid Abubaker, Nuzhat Ahmed|BMC Cancer|2014Cited by 125
Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced tumor burdenKhalid Abubaker|DOAJ (DOAJ: Directory of Open Access Journals)|2014Cited by 78
Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor BurdenKhalid Abubaker, Nuzhat Ahmed|Frontiers in Oncology|2014Cited by 9